Quick Answer
INSMED Inc reported Cash and Equivalents of $510.44 million for fiscal year 2025.
INSMED Inc Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $510.44M | -8.0% |
| 2024 | $555.03M | +15.1% |
| 2023 | $482.37M | -55.1% |
| 2022 | $1.07B | +49.8% |
| 2021 | $716.78M | +34.5% |
| 2020 | $532.76M | +9.3% |
| 2019 | $487.43M | -1.5% |
| 2018 | $495.07M | +29.9% |
| 2017 | $381.17M | +134.4% |
| 2016 | $162.59M | -42.5% |
| 2015 | $282.88M | +77.7% |
| 2014 | $159.23M | +39.8% |
| 2013 | $113.89M | +25.5% |
| 2012 | $90.78M | +511.4% |
| 2011 | $14.85M | +38.2% |
| 2010 | $10.74M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $334.76M | -27.5% | -73.9% |
| June 30, 2025 | $1.28B | +3.0% | +218.5% |
| March 31, 2025 | $403.25M | -32.3% | -27.3% |
| December 31, 2024 | $555.03M | +15.1% | +20.3% |
| September 30, 2024 | $461.45M | -5.3% | -63.0% |
| June 30, 2024 | $1.25B | +103.4% | +109.3% |
| March 31, 2024 | $595.73M | -38.5% | +23.5% |
| December 31, 2023 | $482.37M | -55.1% | -1.0% |
- INSMED Inc showed a decrease of -8.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2025 period, INSMED Inc’s cash and equivalents has grown by 4651.4% (from $10.74 million to $510.44 million).
- The most recent figure is from INSMED Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: